Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phentermine/Topiramate for Weight Regain Prevention in Adolescents With Severe Obesity
NCT04298203Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Aug 2021
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obesity comparing Phentermine/Topiramate with Placebo (2 arms). Primary endpoints: Body Mass Index at 58 weeks, Total body fat at 58 weeks and 7 more. Started Aug 2021; status: completed.
02
Drugs
phenterminetopiramate
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04298203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04298203.